eltrombopag

Ukraine

Drugs containing this active substance

  • ELPATRO

    The drug is used to treat adults and children (from 1 year of age) with chronic immune (idiopathic) thrombocytopenic purpura (ITP) that is unresponsive to other treatments. It is also prescribed for the treatment of thrombocytopenia in patients with chronic hepatitis C and adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC: B02BX05

    Manufacturer: Hetero Labs Limited

  • The drug is used to treat adults and children (from 1 year of age) with chronic immune (idiopathic) thrombocytopenic purpura (ITP) that is unresponsive to other treatments. It is also prescribed for the treatment of thrombocytopenia in patients with chronic hepatitis C and for adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC: B02BX05

    Manufacturer: Hetero Labs Limited

  • The drug is used for the treatment of adults and children (from 1 year of age) with chronic immune (idiopathic) thrombocytopenia that is unresponsive to other treatments. It is also prescribed to adults for the treatment of thrombocytopenia associated with chronic hepatitis C and to adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag 75 mg

    ATC: B02BX05

    Manufacturer: Hetero Labs Limited

  • The drug is used to treat adults and children (from 1 year of age) with chronic immune thrombocytopenic purpura that has not responded to other treatments. It is also prescribed for the treatment of thrombocytopenia in chronic hepatitis C and for adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC: B02BX05

    Manufacturer: Synthon Hispania, S.L. (batch release, manufacturing, primary, secondary packaging, batch control)

  • The drug is used to treat adults and children (from 1 year of age) with chronic immune thrombocytopenic purpura that is unresponsive to other treatments. It is also prescribed for the treatment of thrombocytopenia in chronic hepatitis C and for adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC: B02BX05

    Manufacturer: Synthon Hispania, S.L. (batch release, manufacturing, primary, secondary packaging, batch control)

  • The drug is used for the treatment of patients with chronic immune (idiopathic) thrombocytopenic purpura (aged 1 year and older), thrombocytopenia in adults with chronic hepatitis C, as well as for the treatment of adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag 25 mg

    ATC: B02BX05

    Manufacturer: Glaxo Operations UK Ltd (manufacturing, quality control)

  • The drug is used for the treatment of patients with chronic immune (idiopathic) thrombocytopenic purpura (aged 1 year and older), thrombocytopenia in adults with chronic hepatitis C, as well as for the treatment of adults with severe aplastic anemia.

    Form: tablets, film-coated

    Active substance Dosage
    eltrombopag 50 mg

    ATC: B02BX05

    Manufacturer: Glaxo Operations UK Ltd (manufacturing, quality control)